Study Shows Benefits Of Starting Annual Screening Mammography At 40.

Thursday, August 31, 2017

HealthImaging (8/30, Walter) reports that research suggests “starting annual screening mammography for breast cancer at age 40 helps detect a significant number of cancers.” The article points out that “some advocacy groups, including the American College of Radiology, recommend starting annual screening at age 40, while other groups, such as the U.S. Preventive Services Task Force (USPSTF), recommend women wait and begin biennial screening at age 50.” The study was published in the American Journal of Roentgenology. 

Breast MRI May Be Effective For Postpartum Breast Cancer, Study Suggests.

Thursday, August 31, 2017
Aunt Minnie (8/30, Forrest) reports on a study published in the American Journal of Reoengenology, finding that using an MRI on women with breast cancer within a year of “giving birth can achieve sensitivity of almost 100% for detecting tumors and changes surgical management in more than one in four cases.” The study contradicts the “common view that pregnancy-related hormonal changes and background parenchymal enhancement make breast MRI ineffective for women with pregnancy-associated breast cancer.” One of the authors of the study concludes, “We still were able to see 98% of the tumors, and we were still able to detect clinically relevant additional disease in many of the patients, which impacted surgical management in 28%, even in that first year postpartum.” 

Earlier Mammograms Reduce Number Of Breast-Cancer Related Deaths Among Women Aged 40 And Older, Study Suggests.

Tuesday, August 22, 2017

Reuters (8/21, Seaman) reports a study published in Cancer found that annual mammograms beginning at the age of 40 would prevent the most deaths due to breast cancer, finding that guidance suggesting yearly screenings could reduce the number of deaths among women aged 40 to 80 by 40 percent compared to a reduction of 23 to 31 percent based on current screening recommendations. 

Study Says 2D Synthesized DBT Screening Is Ready For Clinical Use.

Thursday, August 17, 2017
Aunt Minnie (8/17, Yee) reports a recent study in Breast Cancer Research and Treatment suggests that breast cancer screening with synthesized 2D digital breath tomosynthesis (DBT) is “ready routine clinical use.” Study lead Dr. Phoebe Freer from the University of Utah’s Huntsman Cancer Institute said an added benefit is that “women are exposed to less radiation when synthesized 2D images are used withDBT.” Freer told Aunt Minnie, “Our study shows that synthesized mammography images are a fully feasible and adequate option for DBT.” She added that it was fine for practices that have not implemented tomosynthesis to “go straight to synthesized 2D images, rather than having an interim phase of using digital mammography with DBT.”

Breast MRI To Evaluate Newly Diagnosed Breast Cancer May Not Be Linked To Delay In Treatment, Study Suggests.

Wednesday, August 16, 2017

The Radiology Business Journal (8/11) reported that while “breast MRI is often used to evaluate newly diagnosed breast cancers...there is some evidence that suggests this practice can lead to delayed surgical treatment.” Research on 189 women diagnosed with and treated for breast cancer found “that the median time to treatment was 32 days for patients who received pretreatment breast MRI and 34.5 days for patients whodid not receive pretreatment breast MRI.” Meanwhile, “even when a second lesion was discovered during the MRI, leading to an additional biopsy, it ‘did not indicate any significant delayed surgical treatment.’” The findings were published in the Journal of the American College of Radiology.